Efficacy of Moderate Sedation for Dental Treatment of Young Children

NCT ID: NCT00902395

Last Updated: 2015-01-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

41 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-06-30

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is lack of clinical trials on pediatric dental sedation. The purpose of this study is to test (using a randomized controlled trial design) the hypothesis that young children behavior during dental treatment improves with oral midazolam sedation. A further aim of this study was is explore whether behavior also changes over sessions needed to dental treatment completion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There is a lack of clinical trials on pediatric dental sedation in children 3 years old and under. We investigated whether young children's behavior improves during dental treatment with combined oral ketamine and midazolam compared to midazolam alone or no sedation. Healthy children under 36 months of age, presenting early childhood caries and referred to a pediatric dental sedation clinic were randomly assigned to receive combined midazolam (0.5 mg/kg) and ketamine (3 mg/kg) (MK), oral midazolam (1.0 mg/kg) (MS), or protective stabilization without sedative (PS). One observer scored children's behavior using the Ohio State University Behavior Rating Scale (OSUBRS) at determined points in a dental exam (no sedative) and treatment session. Data were analyzed using non-parametric bivariate tests.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Caries Child Behavior Conscious Sedation Failure During Procedure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Midazolam

Oral midazolam

Group Type ACTIVE_COMPARATOR

Midazolam

Intervention Type DRUG

Oral midazolam 1.0 mg/kg (maximum 20 mg)

Midazolam/ketamine

Combined midazolam and ketamine

Group Type EXPERIMENTAL

Midazolam, ketamine

Intervention Type DRUG

Combined oral midazolam (0.5 mg/kg) and ketamine (3 mg/kg) (MK)

Protective stabilization

No drug or placebo administered

Group Type OTHER

Protective stabilization

Intervention Type BEHAVIORAL

Children will receive a protective stabilization (physical restrain) with sheet fixed with tapes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Midazolam

Oral midazolam 1.0 mg/kg (maximum 20 mg)

Intervention Type DRUG

Protective stabilization

Children will receive a protective stabilization (physical restrain) with sheet fixed with tapes.

Intervention Type BEHAVIORAL

Midazolam, ketamine

Combined oral midazolam (0.5 mg/kg) and ketamine (3 mg/kg) (MK)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Dormire, Cristalia, Sao Paulo, Brazil No drug administered Dormire, Cristalia, Sao Paulo, Brazil Ketamin S+, Cristalia, Sao Paulo, Brazil

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy children (ASA PS 1)
* Children under 36 months old
* Children presenting early childhood caries
* Children with no history of dental treatment

Exclusion Criteria

* Lost to follow-up
Minimum Eligible Age

12 Months

Maximum Eligible Age

36 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

Sponsor Role collaborator

Universidade Federal de Goias

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Luciane Ribeiro de Rezende Sucasas da Costa

Associate Professor, Faculty of Dentistry

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Luciane R Costa, DDS, MS, PhD

Role: PRINCIPAL_INVESTIGATOR

Faculty of Dentistry, Federal University of Goias

Paulo S Sucasas, MD, MS, PhD

Role: PRINCIPAL_INVESTIGATOR

Medical School, Federal University of Goias

Thiago A C Moreira, MD

Role: STUDY_CHAIR

Health Sciences Graduate Program, UFG

Denise E Antunes, DDS, PhD

Role: STUDY_CHAIR

Health Sciences Graduate Program, UFG

Cristiana M Jesus-Franca, DDS, PhD

Role: STUDY_CHAIR

Health Sciences Graduate Program, UFG

Hugo S G Oliveira, MD

Role: STUDY_CHAIR

Health Sciences Graduate Program, UFG

Onofre A Neto, MD, PhD

Role: STUDY_CHAIR

Faculty of Medicine, UFG

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dental School

Goiânia, Goiás, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

References

Explore related publications, articles, or registry entries linked to this study.

Moreira TA, Costa PS, Costa LR, Jesus-Franca CM, Antunes DE, Gomes HS, Neto OA. Combined oral midazolam-ketamine better than midazolam alone for sedation of young children: a randomized controlled trial. Int J Paediatr Dent. 2013 May;23(3):207-15. doi: 10.1111/j.1365-263X.2012.01246.x. Epub 2012 May 28.

Reference Type RESULT
PMID: 22631626 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UFG SAP 18189

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Propofol in Obese Children
NCT01242241 COMPLETED PHASE3
Sedation and Memory Consolidation
NCT05045170 COMPLETED NA